Antibacterial Drugs Market to Reach US $38.9 Bn by 2023
The global antibacterial drugs market, according to TMR, could expand at a CAGR of 1.30% between 2015 and 2023 to achieve a revenue valuation of nearly US$38.9 bn by the final forecast year. Although ?-lactams had dominated the market in the past with a larger share, the drug class could lose its share to miscellaneous antibacterials, which are projected to rise at a higher growth rate during the forecast period. Apart from leading the market currently, Asia Pacific could showcase...
View full press release